Prevalence of Dementia and Delirium in Outpatient Clinics (DESTAN Trial)
Gulhane Training and Research Hospital
Gulhane Training and Research Hospital
Sponsor study identifier
observational
714
1 country
1
Study Start
August 5, 2021
Actual (reported)Primary Completion
October 5, 2022
Actual (reported)Study Completion
November 11, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The aim of this study is to assess the prevalence and etiologic risk factors of delirium in outpatient geriatric patients and also hospitalized patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 11, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 4, 2021
Actual (reported)July 22, 2021
Actual (reported)August 5, 2021
Actual (reported)October 5, 2022
Actual (reported)November 11, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
frequency of Mortality
1st year mortality according to the electronic national data base
1 year fellow-up
Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay. Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR). Dementia was defined by a CDR score of 1. The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.
Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay. Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR). Dementia was defined by a CDR score of 1. The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.
Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay. Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR). Dementia was defined by a CDR score of 1. The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.
Participants enrolled in the Delirium group according to the CAM.
Participants enrolled in the Dementia group according to the CDR scores and MMSE scores and DSM4/5 criteria
Community-dwelling older adults (65 years and older)
Contact the study team to confirm eligibility.
Gulhane training and research hospital
Ankara, 06670, Turkey (Türkiye)
Katipoglu B, Demircan SK, Naharci MI. Association of drug burden index with delirium in community-dwelling older adults with dementia: a longitudinal observational study. Int J Clin Pharm. 2023 Oct;45(5):1267-1276. doi: 10.1007/s11096-023-01551-7. Epub 2023 Mar 18.
Mehmet Naharcı
Saglik Bilimleri Universitesi
First Submitted
July 4, 2021
First Posted
July 22, 2021
Study Start
August 5, 2021
Actual (reported)Primary Completion
October 5, 2022
Actual (reported)Dexmedetomidine Effect on Delirium of Elderly Patients
Delirium was detected using the short form of the Confusion Assessment Method (CAM) both at admission and daily throughout the hospital stay. Cognitive status was determined using the Mini-Mental State Exam, Clinical Dementia Rating (CDR). Dementia was defined by a CDR score of 1. The primary independent variable was a composite of delirium and dementia diagnosis, and we examined the overlap by categorizing the cases into four groups: no delirium or dementia, dementia alone, delirium alone, and DSD.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Study Completion
November 11, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 25, 2022
Record last verified: 2022-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: